Congratulations Michael E. Greenberg, Erin schuman, and Christine Holt!

Congratulations ravi jagasia and team Roche!

We are excited to announce the launch of the Institute of Human Biology. The institute brings together scientists from academia and industry to accelerate breakthroughs in R&D, using human model systems. $RHHBY $ROG #RocheInnovation #Science roche.com/media/releases…

Academic researchers from around the world with experience in human in vitro model systems / #organoids : If interested to join us, please reach out institutehumanbiology.com Institute of Human Biology

This is a fantastic opportunity at the intersection of academia and industry, where you can have the best of both worlds in the vibrant city of Basel!

We are very excited to collaborate with Ionis , continuing our deep commitment to finding treatments for #Alzheimer's and #Huntington's diseases! Thanks to the many colleagues who made this partnership possible!

Congratulations Hongkui Zeng!

So humbled and grateful to @WUSTLneurosci for this incredible honor!! Super excited and looking forward to share a wonderful day of science with colleagues and friends from around the world at Washington University in St. Louis @WUSTL!!

Here is the leading edge of #RNAtherapeutics!

Pleased to share our paper in Nature Medicine presenting an exploratory analysis of a Phase 2 study in Parkinson's disease! It is a significant step forward toward developing a treatment that can effectively slow the progression of Parkinson's disease. nature.com/articles/s4159…

Excited about the partnership with Ascidian Therapeutics, which aligns with Roche pRED's gene therapy strategy in neuroscience! The collaboration promises to advance treatments for patients with devastating neurological disorders. #Neuroscience #RewritingRNA #RNAExonEditing #genetherapy

Congratulations Denis A. Engemann and colleagues on your publication! This area of research is critical to our ability to develop novel biomarkers for the study of brain disorders. Keep up the great work!

Congratulations Hao Chen, Cole J Ferguson, MD, PhD, and Albert H. Kim as well as collaborators for an exciting study and identification of a novel ubiquitin signaling link in the brain with implications for understanding genetic neurodevelopmental disorders!

Delighted to announce Luka Kulic has been appointed VP & Head of Early Development in Neuroscience & Rare Diseases at Roche pRED! Luka brings expertise and proven track record to advance our early clinical pipeline toward medicines for patients with neurological disorders!

In case you missed it: I am proud to share one of our studies from the summer, in which we report a conceptual advance in the science and medicine of ubiquitin signaling in genetic neurodevelopmental disorders! nature.com/articles/s4159…